Tinea barbae
Chapter 1:Certain infectious and parasitic diseases
ICD-10 B35.0 is a billable code used to indicate a diagnosis of tinea barbae.
Tinea barbae is a fungal infection that primarily affects the beard area in men, caused by dermatophytes, particularly Trichophyton species. This condition is characterized by erythematous, scaly patches that may progress to pustules and crusting. It often presents with pruritus and can lead to secondary bacterial infections if left untreated. Tinea barbae is typically contracted through direct contact with infected individuals or contaminated objects, such as razors or towels. The infection is more prevalent in individuals with poor hygiene, those who frequently shave, and in warm, humid environments. Immunocompromised patients, such as those with diabetes or HIV/AIDS, are at a higher risk for developing more severe forms of tinea barbae, which may require more aggressive antifungal treatment. Diagnosis is usually made clinically, but can be confirmed through KOH preparation or culture of the affected area. Treatment typically involves topical antifungals like clotrimazole or terbinafine, and in more severe cases, systemic antifungals may be necessary.
Detailed clinical notes including lesion description, location, and treatment plan.
Patients presenting with itchy, scaly patches in the beard area, often after shaving.
Consideration of differential diagnoses such as folliculitis or psoriasis.
Comprehensive history of immunocompromised conditions and treatment response.
Immunocompromised patients with recurrent or severe tinea barbae.
Need for thorough evaluation of systemic antifungal therapy.
Used for follow-up visits for tinea barbae treatment.
Document the patient's history, examination findings, and treatment plan.
Dermatologists may require more detailed documentation of skin findings.
Common treatments include topical antifungals such as clotrimazole or terbinafine, and systemic antifungals like itraconazole or fluconazole for more severe cases.
